Daily Digest
Crowdfunding enables gene therapy for infant with SMA
Published Thursday, October 8, 2026
Narrative Spectrum
- Single-Source Coverage — 1 source
What We Know — Key Points
Key points are extracted by an AI model and may contain errors or omissions. Always check the original sources.- A seven-month-old infant received onasemnogene abeparvovec gene replacement therapy at Aster CMI Hospital in Bengaluru.
What Is Claimed — Perspectives
Single-Source Coverage
- The Hindu
The article emphasizes the critical role of early diagnosis and the financial hurdles families face in accessing expensive gene therapies for rare conditions like SMA, showcasing crowdfunding as a viable solution.
- Read original →· Oct 8
AI-Generated Content
- This topic was generated by an AI system.
- Key points, perspectives, bias labels, and categorisation may contain errors.
- This is not journalism. Do not rely on this content for critical decisions.
- Read our full AI disclaimer for details.